PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
7840911-7	1994	There was a correlation between the plasma didanosine concentration and an improvement in IQ (Intelligence Quotient) and p24 status.	Didanosine	43-53	transmembrane p24 trafficking protein 2	Homo sapiens	121-124	
8089546-4	1994	Culture of 2 isolates from two patients treated with AZT more than 6 months before switched to ddI therapy showed CPE in the presence of AZT and HIV-1 p24 antigen was detected by ELISA in the supernatants.	Didanosine	95-98	transmembrane p24 trafficking protein 2	Homo sapiens	151-154	
8089546-5	1994	Culture of 6 of 7 isolates from three patients treated with ddI after long-term therapy with AZT also showed CPE in the presence of 1.0 microM AZT and HIV-1 p24 antigen was detected.	Didanosine	60-63	transmembrane p24 trafficking protein 2	Homo sapiens	157-160	
8425018-3	1993	Didanosine therapy was associated with a significant increase in CD4 counts and a prolonged decrease in serum levels of p24 antigen relative to baseline.	Didanosine	0-10	transmembrane p24 trafficking protein 2	Homo sapiens	120-123	
8426301-1	1993	Didanosine (ddI) is a purine analogue that demonstrates in vitro anti-human immunodeficiency virus (HIV) activity, effects on the surrogate markers CD4+ T-lymphocytes and p24 antigen, and has adequate oral bio-availability.	Didanosine	0-10	transmembrane p24 trafficking protein 2	Homo sapiens	171-174	
8426301-1	1993	Didanosine (ddI) is a purine analogue that demonstrates in vitro anti-human immunodeficiency virus (HIV) activity, effects on the surrogate markers CD4+ T-lymphocytes and p24 antigen, and has adequate oral bio-availability.	Didanosine	12-15	transmembrane p24 trafficking protein 2	Homo sapiens	171-174	
1350471-10	1992	Phase I studies indicate that ddI has a beneficial effect on the CD4+ cell counts and HIV p24 antigen concentrations.	Didanosine	30-33	transmembrane p24 trafficking protein 2	Homo sapiens	90-93	
1347442-0	1992	Relationship between dideoxyinosine exposure, CD4 counts, and p24 antigen levels in human immunodeficiency virus infection.	Didanosine	21-35	transmembrane p24 trafficking protein 2	Homo sapiens	62-65	
1347442-2	1992	OBJECTIVE: To determine the relation between exposure to dideoxyinosine (ddl) and increased CD4 cell counts and suppression of serum p24 antigen in patients infected with the human immunodeficiency virus (HIV).	Didanosine	57-71	transmembrane p24 trafficking protein 2	Homo sapiens	133-136	
1727902-4	1992	A plasma ddI concentration-response relationship was observed for both decline in viral p24 antigen levels and improvement in intelligence quotient score.	Didanosine	9-12	transmembrane p24 trafficking protein 2	Homo sapiens	88-91	
2139173-9	1990	The administration of ddI was associated with statistically significant decreases in serum level of p24 antigen and increases in the numbers of CD4 cells at 2, 6, 10, and 20 weeks.	Didanosine	22-25	transmembrane p24 trafficking protein 2	Homo sapiens	100-103